의료 시뮬레이션 시장 보고서 : 제품 및 서비스별, 피델리티별, 최종사용자별, 지역별(2025-2033년)

The global medical simulation market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.5 Billion by 2033, exhibiting a growth rate (CAGR) of 11.21% during 2025-2033. The rising demand for minimally invasive surgeries, ongoing technological advancements, growing focus on patient safety, and shortage of healthcare professionals are primarily proliferating the market's growth.

Medical Simulation Market Trends:

Rising Demand for Minimally Invasive Surgery

The growing trend of minimally invasive surgery (MIS) is a significant driver of the medical simulation market growth. For instance, according to IMARC, the global minimally invasive surgery market size reached US$ 52.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 91.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. Minimally invasive surgeries involve smaller incisions, fewer complications, and faster recovery times compared to traditional open surgeries, but they require a high level of skill and precision from surgeons. Medical simulation provides an ideal platform for training healthcare professionals in these advanced techniques. These factors are expected to propel the medical simulation industry in the coming years.

Shortage of Healthcare Professionals

The shortage of healthcare professionals is a key driver of growth in the medical simulation market. For instance, by 2025, Mercer, a consulting firm, forecasted a shortage of almost 400,000 home health aides and 29,400 nurse practitioners. There will also be a shortage of other healthcare professionals. Also, the World Health Organization (WHO) predicted a 10 million health professional shortage by 2030, primarily in low- and lower-middle-income nations. As healthcare systems globally face significant workforce shortages, medical simulation provides an efficient and scalable solution to train and prepare healthcare professionals. These factors further positively influence the medical simulation market forecast.

Technological Advancements

Technological advancements have significantly transformed the medical simulation market. VR and AR are revolutionizing medical simulation by creating highly immersive, interactive environments that allow learners to practice procedures and decision-making in a virtual setting. For instance, in July 2024, MediSim VR, a healthcare simulation training technology provider, launched Chennai's first Center of Excellence (CoE) VR lab at Sri Ramachandra Institute of Higher Education and Research (SRIHER). This cutting-edge institution provides immersive and interactive VR training to medical students nationwide, thereby boosting the medical simulation market share.

Global Medical Simulation Industry Segmentation:

Breakup by Product and Services:

• Model-based Simulation
• Surgical Simulation
• Ultrasound Simulation
• Web-based Simulation
• Simulation Training Services

According to the medical simulation market outlook, model-based simulation refers to the use of physical or digital models to represent human anatomy, physiological systems, or medical processes. These models simulate how the human body responds to treatments, procedures, and interventions in real-time. Moreover, surgical simulation involves replicating real-life surgical procedures through both physical and virtual means. It helps surgeons develop skills, practice procedures, and refine techniques before performing them on real patients. Apart from this, ultrasound simulation is a specific type of medical simulation designed to train healthcare professionals in the use of ultrasound technology for diagnostic and interventional procedures.

Breakup by Fidelity:

• Low Fidelity
• Medium Fidelity
• High Fidelity

According to the medical simulation market overview, low fidelity simulations are basic, often static, representations of medical scenarios. These simulations usually focus on simple skills, concepts, or procedures without offering high levels of realism or interaction. While medium simulation offers more interactivity and realism than low fidelity, they are not as complex as high fidelity simulations. They may involve some dynamic features, such as vital signs or limited physiological responses, and often simulate more comprehensive clinical scenarios. Besides this, high fidelity simulations are the most realistic and sophisticated types of simulation. They replicate real-life clinical scenarios as closely as possible, often using advanced technologies like interactive manikins, virtual reality (VR), and augmented reality (AR). High fidelity simulations are designed to immerse learners in a scenario that closely mimics real-world conditions.

Breakup by End User:

• Hospitals and Clinics
• Academic Institutions and Research Centers
• Military Organizations
• Others

Hospitals and clinics are under increasing pressure to improve patient safety and reduce the incidence of medical errors. Medical simulation offers a safe and controlled environment for healthcare professionals to practice procedures and refine their clinical skills without risking patient harm. Moreover, medical schools and training institutions are increasingly incorporating simulation-based learning into their curricula as a primary teaching tool. This shift is driven by the need to provide medical students and residents with more hands-on experience before they engage with real patients.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

According to the medical simulation market statistics, North America holds the prominent share of the global medical simulation market, driven by high healthcare expenditure, well-established healthcare infrastructure, and early adoption of advanced technologies like virtual reality (VR) and augmented reality (AR). Also, advanced healthcare institutions in the U.S. are early adopters of high-fidelity medical simulators, VR, and AI-driven simulation platforms. Moreover, Europe is a significant region for the medical simulation market, with Germany, France, and the United Kingdom being the largest contributors. Furthermore, European governments and healthcare organizations are promoting simulation-based training to improve the skills of healthcare professionals and ensure compliance with international standards for patient safety.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• Cardionics Inc. (3B Scientific GmbH)
• Gaumard Scientific Company Inc.
• Kyoto Kagaku Co. Ltd
• Laerdal Medical
• Mentice
• Operative Experience Inc.
• Simbionix USA Corporation (3D Systems)
• Simulab Corporation
• Surgical Science Sweden AB
• Synaptive Medical Inc.
• SynBone AG
• VirtaMed AG.

Key Questions Answered in This Report:

• How has the global medical simulation market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global medical simulation market?
• What are the key regional markets?
• What is the breakup of the market based on the product and services?
• What is the breakup of the market based on the fidelity?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global medical simulation market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Simulation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product and Services

• 6.1 Model-based Simulation
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Surgical Simulation
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Ultrasound Simulation
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Web-based Simulation
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Simulation Training Services
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Fidelity

• 7.1 Low Fidelity
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Medium Fidelity
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 High Fidelity
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Academic Institutions and Research Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Military Organizations
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Cardionics Inc. (3B Scientific GmbH)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Gaumard Scientific Company Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Kyoto Kagaku Co. Ltd
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Laerdal Medical
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Mentice
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 Operative Experience Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Simbionix USA Corporation (3D Systems)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Simulab Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Surgical Science Sweden AB
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Synaptive Medical Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 SynBone AG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 VirtaMed AG
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio